30%Oxygen
20230724-2
Approved small_molecule completed
Quick answer
30%Oxygen for Atelectasis, Postoperative is a Approved program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Atelectasis, Postoperative
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed